A total of 456 non-repetitive Escherichia coli isolates from human clinical specimens (urinary, n5134; cervix, vagina and prostate, n552; blood, pus and wounds, n545), healthy animals (cattle, n545; poultry, n520) and diseased animals (cattle, n553; swine, n564; poultry, n543) obtained in Lithuania during the period 2005-2008 were studied for trimethoprim (TMP) resistance and the prevalence of dfr genes. A TMP resistance rate in the range of 18-26 % respective to the origin was found in clinical isolates, 23-40 % in isolates from diseased animals and 9-20 % in isolates from healthy animals. Of 112 TMP-resistant isolates, 103 carried at least one of the six dfrA genes (dfrA1, dfrA5, dfrA8, dfrA12, dfrA14 and dfrA17) as determined by multiplex PCR and RFLP. The dfrA1 and dfrA17 genes were found most frequently in clinical isolates (17 and 19 isolates, respectively), whilst dfrA1 and dfrA14 genes dominated in isolates of animal origin (25 and 13 isolates, respectively). The dfrA5, dfrA12 and dfrA8 genes were detected at lower frequencies. The association with class 1/class 2 integrons was confirmed for 73-100 % of dfr genes found in most groups of isolates, except for the isolates from diseased swine. In this group, the majority of dfr-positive isolates (67 %, 8/12) carried dfrA8 (6/12) or dfrA14 genes (2/12) that were not associated with integrons. Non-integron location was also confirmed for the remaining dfrA8 genes (six clinical isolates and one isolate from diseased cattle) and for dfrA14 genes (two isolates from diseased cattle and swine each). All cassetteindependent dfrA14 genes were found to be located within the strA gene. This study on the prevalence and distribution of TMP resistance genes among E. coli isolates of human and animal origin in Lithuania demonstrates that dfr genes are carried most frequently as gene cassettes within class 1 and/or class 2 integrons. However, TMP resistance in some of the isolates was found to be mediated by non-integron-associated dfrA8 and dfrA14 genes, indicating the existence of alternative sources for the spread of resistance.
INTRODUCTION
Trimethoprim (TMP) affects bacterial folic acid synthesis by the inhibition of dihydrofolate reductase (DHFR), which catalyses the reduction in dihydrofolate (Huovinen, 2001; Sköld, 2001) . Bacteria may become resistant to TMP by several mechanisms, including the development of permeability barriers, efflux pumps, the existence of naturally insensitive target DHFR enzymes, mutational and regulation changes in target enzymes and the acquirement of drug-resistant target enzymes (Huovinen, 2001) . The most common resistance mechanism is the acquirement of a TMP-insensitive DHFR variant resulting in high-level TMP resistance in various bacteria. To date, more than 30 different TMP resistance dfr genes are known. On the basis of the length of encoded polypeptide, they have been divided into two major types, dfrA and dfrB (White & Rawlinson, 2001 ).
The association of dfr genes with mobile genetic elements such as transposons and plasmids has often been observed (Ojo et al., 2002; Sundström et al., 1995) . Most dfr genes are found to reside as gene cassettes within variable parts of integrons, which has resulted in the rapid spread of TMP resistance in various bacteria (Blahna et al., 2006) . Of the five known integron classes, class 1 and class 2 integrons have been shown to harbour dfr gene cassettes. The dfrA1, dfrA5, dfrA7, dfrA12, dfrA14, dfrA17, dfrA22 and dfrA27 gene cassettes have been found to be present within variable regions of class 1 integrons (Blahna et al., 2006; Grape et al., 2005; Kadlec & Schwarz, 2008; Lee et al., 2001; Wei et al., 2009) . dfrA1 and more recently dfrA14 have been shown to be associated with class 2 integrons (Kadlec & Schwarz, 2008; Márquez et al., 2008) .
Escherichia coli is the most frequent Gram-negative bacterium isolated from blood cultures in clinical settings, as well as the most frequent cause of community and hospital-acquired urinary tract infections (UTIs) (Wiles et al., 2008; Yamamoto, 2007) . TMP, most commonly in combination with sulfonamides (sulfamethoxazole), is the antimicrobial of choice for the treatment of UTIs and respiratory and gastrointestinal tract infections (Masters et al., 2003) . Resistance to TMP among clinical E. coli isolates varies greatly, ranging from 10 to 70 % in different parts of the world (Kahlmeter & ECO.SENS, 2003; Lee et al., 2001) . The presence of dfr gene cassettes within integrons is a potential source of horizontal spread of TMP resistance among bacteria present in different environments, including livestock, where TMP is used for antimicrobial therapy and prophylaxis of food-producing animals (Mathew et al., 2007; Prescott, 2008) .
Systematic data on antibiotic consumption and the prevalence of antibiotic resistance at the national level in Lithuania have been lacking until recently. However, several studies have revealed the extensive use of antimicrobials for clinical therapy and in livestock, the high prevalence of self-medication in the country and an increase in antibiotic resistance of some important human pathogens (Beržanskytė et al., 2006; EARSS Management Team, 2008; Grigoryan et al., 2006; Špakauskas et al., 2004) . During the period 1994-2002, E. coli was isolated as a major infection agent of childhood UTIs in two of the largest children's hospitals in Lithuania, with the prevalence of TMP resistance ranging from 17.5 to 35.5 % (Kaltenis et al., 2003; Pundzienė et al., 2003) . Despite these observations, the prevalence of TMP-resistant bacterial isolates from different environments in Lithuania is not clear, and the molecular basis of resistance has not been investigated.
In this study, we analysed TMP resistance in E. coli isolates of human and animal origin in Lithuania obtained during the period 2005-2008, the distribution of dfr genes and their association with class 1/class 2 integrons and other genetic structures.
METHODS
Bacterial isolates. A total of 231 and 225 E. coli isolates of human and animal origin, respectively, were isolated during the period [2005] [2006] [2007] [2008] . The bacterial isolates of human origin were collected randomly from diverse units of nine hospitals located in different regions of Lithuania and were recovered from patients with various infections from urine (n5134), cervix, vagina and prostate (n552), and blood, pus and wounds (n545). A single isolate per patient was selected before antibiotic treatment.
The bacterial isolates of animal origin were obtained from 23 farms (eight cattle, ten swine and five poultry) from different regions of the country. E. coli isolates from healthy animals (cattle, n545; poultry, n520) and animals with various disease conditions (cattle, n553; swine, n564; poultry, n543) were selected for further testing. All isolates from healthy animals were obtained from faeces. The isolates from diseased animals were obtained from faeces or from internal organs (poultry). Diarrhoea in all animal species as well as chronic respiratory disease in poultry were the main manifestations of disease. Only one randomly selected isolate per healthy animal (in the case of diseased animals, only one typable or non-typable isolate) from one herd was used for further testing. Samples were obtained before treatment with antimicrobial drugs.
E. coli strains were initially isolated on MacConkey agar (Oxoid). Biochemical properties were determined using Microbact plates and results were interpreted using Microbact 2000 (Oxoid).
Antimicrobial susceptibility testing. Antibiotic susceptibility testing was performed by the disc diffusion (Kirby-Bauer) method according to Clinical and Laboratory Standards Institute (CLSI) guidelines (CLSI, 2006) . The isolates were interpreted as susceptible or resistant according to the inhibition zone diameter using CLSI recommendations. Intermediate susceptible strains were considered as non-susceptible. Discs were obtained from Oxoid.
The antimicrobials used for the susceptibility testing of E. coli clinical isolates were as follows (mg per disc): ampicillin (10 mg), ampicillinsulbactam (10/10 mg), gentamicin (120 mg), TMP-sulfamethoxazole (1.25/23.75 mg), ciprofloxacin (5 mg), cefuroxime (30 mg), cefotaxime (30 mg), piperacillin-tazobactam (100/10 mg), norfloxacin (10 mg) and nitrofurantoin (300 mg).
The antimicrobials used for the susceptibility testing of E. coli isolates of animal origin were as follows (mg per disc): ampicillin (10 mg), chloramphenicol (30 mg), gentamicin (10 mg), nalidixic acid (30 mg), tetracycline (30 mg), TMP-sulfamethoxazole (1.25/23.75 mg), ciprofloxacin (5 mg), cephalotin (30 mg), florfenicol (30 mg) and ceftiofur (30 mg).
E. coli ATCC 25922 was used as the reference strain.
Preparation of DNA templates. All bacterial DNA templates used in PCR were prepared by boiling bacterial colonies suspended in 100 ml sterile water. The boiled samples were centrifuged briefly and the supernatants used as DNA templates.
Detection of dfr genes by multiplex PCR and RFLP. In this study, the modified method of Navia et al. (2003) was used, together with newly designed primers for multiplex PCR, targeting all dfr genes published to date. The dfr gene sequences were downloaded from GenBank, compared and grouped by sequence similarity. The primers were designed for analysis of similar genes of groups A1 (dfrA1, dfrA15, dfrA15b, dfrA16, dfrA16b and dfrA28), A5 (dfrA5, dfrA14, dfrA25 and dfrA27), A7 (dfrA7 and dfrA17), A12 (dfrA12, dfrA13, dfrA21 and dfrA22) and B (dfrB1, dfrB2, dfrB3, dfrB4, dfrB5 and dfrB6), and for individual screening of the dfrA3, dfrA3b, dfrA6, dfrA8, dfrA9, dfrA10, dfrA19, dfrA20, dfrA23, dfrA24 and dfrA26 genes ( Table 1) .
The PCR mix (25 ml) included 2 ml template DNA, 16 PCR buffer, 1 U Taq DNA polymerase (AB Fermentas), 200 mM each dNTP, 1 mM each primer ( ) and visualized using a UV transilluminator. The length of amplicons was determined by comparing them with a 100 bp ladder (AB Fermentas).
The appropriate restriction enzymes were selected for RFLP analysis of each homology group of all known dfr genes to distinguish similar genes within the group (Table 1) . The restriction mixture (20 ml) included: 10 ml PCR restriction mixture (~0.1-0.5 mg DNA), 16 recommended buffer for restriction enzyme and 10 U restriction enzyme (AluI, MspI, PvuI, TruI1 or TasI; AB Fermentas). Restriction products were fractionated by gel electrophoresis (3 % agarose in 16 TAE buffer with 0.5 mg ethidium bromide ml 21 ) and the length of the restriction products was determined as above.
Determination of dfr gene localization. The localization of dfr genes within integrons was determined as follows. Isolates containing dfr genes were subjected to PCR to amplify the junction between the 59 conserved segment (59CS) of the class 1/class 2 integrons and the appropriate dfr gene. Forward primers used in this study were FINT-1 (59-GGCATCCAAGCAGCAAG-39) for the class 1 integron and FINT-2 (59-CCGGACGGCATGCACGATTTG-39) for the class 2 integron. The reverse primers complementary to DNA sequences of the dfr genes are listed in Table 1 . Annealing temperatures used were 49 and 51 uC for the class 1 and class 2 integrons, respectively. The length of amplicons varied depending on the position of the dfr gene cassette within the variable region of the integrons.
The integration of dfrA14 within the strA gene was determined by amplification of junction regions. The primer F1APH-3 (59-CTTGGTGATAACGGCAATTCC-39) and the dfrA14 reverse primer (Table 1) were used for amplification of the junction region located upstream of dfrA14. The primer R1APH-3 (59-CCAATCGCAGAT-AGAAGGCAA-39) and the dfrA14 forward primer (Table 1) were used for amplification of the junction region located downstream of dfrA14.
Conjugation experiments. Conjugation experiments were performed by mating E. coli harbouring the dfrA14 gene as a donor strain with rifampicin-resistant E. coli HK225 as recipient strain at a donor : recipient ratio of 1 : 5 as described by Kadlec & Schwarz (2008) . Transconjugants were selected on Luria-Bertani agar plates containing rifampicin (100 mg l 21 ) and TMP (10 mg l 21 ).
Statistical methods. Differences in the prevalence of antibiotic resistance between different groups were assessed by a x 2 or Fisher's exact test. A P value of ,0.05 was considered to be statistically significant. Statistical analyses were performed using GraphPad Prism software.
RESULTS AND DISCUSSION
TMP-resistant E. coli isolates of human and animal origin A total of 456 E. coli isolates of human and animal origin obtained during the period 2005-2008 in Lithuania were tested for antibiotic susceptibility by the disc diffusion method. Of these, 112 (25 %) were found to be TMP resistant. Table 2 shows the frequency of resistance to TMP among the different groups of isolates. Overall, 23 % of human clinical isolates were TMP resistant. Statistical analysis showed that there was no significant difference in the frequency of TMP-resistant human clinical isolates according to the origin. The resistance rate for clinical E. coli isolates was comparable to that found in other European countries: Germany (22.5 %), Ireland (22.1 %), Portugal (26.7 %) and Spain (25.1 %), as observed in the ECO.SENS study (Kahlmeter & ECO.SENS, 2003) . According to the same study, the proportion of TMPresistant E. coli was found to be lowest in Nordic countries and Austria (5.5-9.5 %). The frequency of TMP resistance among animal isolates was 23, 33 and 40 % for diseased swine, poultry and cattle, respectively. Within the healthy animals, 9 % of isolates from poultry and 20 % of isolates from cattle were TMP resistant ( Table 2 ). The observed TMP resistance rate among isolates recovered from *The dfrA1 gene and dfrA17 gene were both found in one isolate.
V. Š eputienė and others diseased cattle and swine was comparable to that reported for some countries in the Baltic region such as Finland and Sweden (Hendriksen et al., 2008a, b; Kahlmeter & ECO.SENS, 2003) . However, a comparison of our findings with geographical areas closer to Lithuania was not possible due to a lack of epidemiological data from neighbouring countries. E. coli from diseased cattle showed a significantly higher TMP resistance rate compared with that for indicator bacteria recovered from healthy cattle (40 vs 9 %, P ,0.05). Similar findings were reported in a complex study on antibiotic resistance among bacterial pathogens and indicator bacteria in animals in Europe, where the prevalence of antibiotic-resistant E. coli strains from diseased pigs was higher than that from healthy pigs (Hendriksen et al., 2008b) . The observed difference in resistance rate is thought to be due partially to the sampling methodology, when isolates recovered from diseased animals generally represent cases of severe disease or treatment failure, possibly resulting in the emergence of resistant pathogens during previous (unsuccessful) therapy.
Identification of dfr genes
We combined multiplex PCR and RFLP methods to search for the 33 currently known dfr genes in selected TMP-resistant E. coli isolates (Table 1 ) (Agersø et al., 2006; Grape et al., 2007b; Wei et al., 2009) . By using this approach, we were able to determine the prevalence and distribution of integron-borne dfr genes and those not carried within known mobile elements in a large collection of isolates of human and animal origin. Of the 112 TMP-resistant E. coli isolates, 103 harboured one of the following genes: dfrA1, dfrA5, dfrA8, dfrA12, dfrA14 and dfrA17. The distribution of dfrA gene variants among different groups of isolates is presented in Table 2 .
The dfrA17 and dfrA1 genes were detected most frequently. One clinical isolate from urine harboured a combination of dfrA1 and dfrA17 genes ( Table 2 ). The dfrA1 gene prevailed in TMP-resistant isolates of animal origin, followed by the dfrA14 gene, whereas the dfrA1 and dfrA17 genes dominated in clinical isolates. Only a single isolate of animal origin (diseased cattle) harboured dfrA17. The latter observation indicates the difference in acquired dfrA17-mediated TMP resistance between E. coli strains of human and animal origin. Our results obtained for clinical isolates are consistent with recent European-Canadian and Swedish studies, in which a prevalence of dfrA1 and dfrA17 genes in E. coli isolates from UTIs was observed (Blahna et al., 2006; Grape et al., 2007a) .
Unexpectedly, we observed that the dfrA14 gene was among the most prevalent dfr genes in TMP-resistant E. coli animal isolates, in contrast to recent reports on the rare incidence of class 1 integron-associated dfrA14 in TMPresistant E. coli strains of animal origin in Germany and Portugal (Kadlec & Schwarz, 2008; Machado et al., 2008) .
The remaining dfr genes identified in this study (dfrA5, dfrA8 and dfrA12) were less prevalent and showed different distribution patterns within the groups of isolates (Table  2) . Nine TMP-resistant isolates (eight isolates of animal origin) were negative for the dfr genes tested.
Association of dfr genes with class 1 and class 2 integrons
To investigate the association of dfr genes with integrons, we amplified the junction of the 59CS of the class 1/class 2 integrons and dfr genes that were identified in this study and are known to be located within the variable regions of integrons (dfrA1, dfrA5, dfrA12, dfrA14, dfrA17; Blahna et al., 2006; Grape et al., 2005; Kadlec & Schwarz, 2008) . The PCR generally yielded amplicons of 590 and 640 bp, indicating that the dfr genes were situated in the first gene cassettes within the variable parts of the class 1 and 2 integrons, respectively. In one case (an isolate from diseased poultry), however, the junction of the class 1 integron and the dfrA1 gene was amplified with a length of 1940 bp, suggesting that the dfr gene cassette was located further downstream within the variable region of the integron.
The association with class 1/class 2 integrons was confirmed for 73-100 % of the dfr genes found in most groups of isolates, except for the isolates from diseased swine, where only four out of 12 identified dfr genes (33 %) were present on integrons (Table 3 ). All dfrA1, dfrA5, dfrA12 and dfrA17 genes identified in this study were found as cassettes within integrons. One human clinical isolate recovered from urine carried dfrA1 in a gene cassette on class 1 and class 2 integrons. Another isolate of this group contained the dfrA1 and dfrA17 genes in cassettes on class 2 and class 1 integrons, respectively.
Analysis of the dfrA14 genes showed their diverse location in isolates obtained from different sources. Thus, all dfrA14 genes in clinical isolates were found on either a class 1 or a class 2 integron, whereas only seven out of 13 dfrA14 genes (54 %) in isolates of animal origin were integronassociated, all of them with class 1, as determined by amplification of the junction between the 59CS and the dfrA14 gene (Table 3) . To our knowledge, this is the first study showing the presence and the frequency of class 1 integron-associated dfrA14 in clinical E. coli isolates. Notably, the incidence of dfrA14 in class 2 integrons appears to be rare, as only one report on the presence of such a structure in a class 2 integron carried by an E. coli isolate from the urinary tract has been published (Márquez et al., 2008) .
Further PCR analysis of the full-length variable regions of dfrA14-positive class 1 integrons using primers annealing to the 59CS and 39CS yielded no products with the exception of two isolates (diseased cattle), suggesting the absence of the 39CS in the majority of isolates (data not shown). A similar finding has been reported previously (Sunde, 2005) and was supported by the recent determination of the nucleotide sequence of a defective dfrA14- containing class 1 integron carried by the plasmid pK245 in a multidrug-resistant Klebsiella pneumoniae isolate (Chen et al., 2006) .
DNA sequencing of the variable regions of integrons confirmed the location of the dfr genes observed in this study. The dfrA1, dfrA17 and dfrA12 gene cassettes were found to be present within the same type of class 1 or class 2 integron in E. coli isolates of human and animal origin, suggesting a horizontal spread of certain integron types among E. coli present in different ecological niches in Lithuania (J. Povilonis, V. Šeputienė, M. Ružauskas, R. Šiugždinienė, M. Virgailis, P. Ž labys, A. Pavilonis and E. Sužiedėlienė, unpublished data).
According to several studies, the rates of resistance to TMP among clinical bacterial isolates are increasing despite the decreased use of TMP or co-TMP in clinical settings (Kärpänoja et al., 2008; Sörberg et al., 2002) . Thus, the proportion of TMP-resistant E. coli urinary isolates in Europe rose from 0 to 5 % before 1990, and to 9-26 % in 2003 (Kahlmeter & ECO.SENS, 2003) . The persistence of and even increase in TMP resistance among bacterial pathogens is thought to be facilitated by the common presence of dfr gene cassettes within integrons and their spread among bacteria present in different environments (e.g. livestock), where specific antibiotic pressure supporting the selection of such genetic structures could still be high (Blahna et al., 2006; Cocchi et al., 2007) .
The trends in TMP consumption and resistance of bacterial pathogens or indicator bacteria were not investigated in Lithuania; however, the high prevalence of integronassociated dfr genes in TMP-resistant E. coli isolates of different origins and TMP resistance rates, similar to those in other European countries, show that a pool of transferable resistance determinants has already been established and disseminated.
Identification of dfr genes not associated with integrons
We analysed further the location of dfrA14 genes for which the association with integrons was not confirmed. For this purpose, we attempted to amplify the junction region between the dfrA14 and strA genes, which has been reported to be the integration site for dfrA14 in a resistance plasmid carried by uropathogenic E. coli (Ojo et al., 2002) . The PCR using DNA from the six isolates of animal origin (two isolates each from diseased cattle, swine and poultry) yielded amplicons of~780 bp (downstream of the dfrA14 gene) and 760 bp (upstream of the dfrA14 gene), confirming disruption of the strA gene by the insertion of a 570 bp DNA fragment containing the dfrA14 gene. The gene arrangement DstrAdfrA14DstrA in these isolates closely resembled one residing within a small transferable plasmid, pSTOJO1 (6.8 kb), isolated from uropathogenic E. coli in Nigeria, which has been shown to lack integron structures (Ojo et al., 2002) . We confirmed the conjugal transfer of the DstrAdfrA14DstrA arrangement at a frequency of 5610 24 c.f.u. per recipient cell. Previous studies have shown that plasmids carrying sul2-strA genes are widespread among Gram-negative bacteria and are capable of accepting other resistance genes, such as catA3 and dfrA14, to form new resistance gene clusters in a response to antibiotic selective pressure (Kehrenberg et al., 2003) . 
V. Š eputienė and others
There is a group of dfr genes that has been shown not to be associated with integrons and is disseminated by other mechanisms such as being part of the common region (dfrA3b, dfrA9, dfrA10, dfrA19, dfrA20, dfrA23 and dfrA26), unknown genetic structures (dfrA3, dfrA24) or transposons (dfrA8) (Sundström et al., 1995; Toleman et al., 2006) . In this study, the dfrA8 gene was identified in half of the dfrpositive isolates recovered from diseased swine (6/12), as well as in human clinical isolates obtained from urine (three isolates) and cervix (three isolates). Of all the dfr genes observed in this study, the dfrA8 gene was found to be neither class 1 nor class 2 integron-associated. This finding is consistent with the observations that dfrA8 does not appear to be a recombination substrate for integrases but has been assembled into the plasmid-borne transposon Tn5091 (Sundström et al., 1995) . Only fragmented studies on the prevalence of dfrA8 among E. coli isolates in Europe and in other countries have been conducted, showing considerable variation (Pallecchi et al., 2007; Sundström et al., 1995) .
In summary, this study showed that integron-associated dfr genes are in most part responsible for the TMP resistance of E. coli isolates of human and animal origin in Lithuania. However, the resistance of some isolates is mediated by cassette-independent dfrA8 and also by dfrA14 present in a non-integron structure, responsible for resistance spread through a conjugative plasmid. For this reason, integronassociated DHFRs seem not to be unique and single players contributing to the current TMP resistance.
